within Pharmacolibrary.Drugs.ATC.A;

model A08AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.00035,
    adminDuration  = 600,
    adminMass      = 120 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00038333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A08AB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Orlistat is a gastrointestinal lipase inhibitor used for the treatment of obesity. It works by inhibiting the absorption of dietary fats in the intestine. Orlistat is approved for both prescription and over-the-counter use in several countries for weight management in conjunction with a reduced-calorie diet.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are based on healthy adult volunteers. Orlistat, due to its minimal systemic absorption, exhibits very low plasma concentrations.</p><h4>References</h4><ol><li><p>Melia, AT, et al., &amp; Zhi, J (1996). The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers. <i>Journal of clinical pharmacology</i> 36(7) 654–658. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1996.tb04231.x\">10.1002/j.1552-4604.1996.tb04231.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8844449/\">https://pubmed.ncbi.nlm.nih.gov/8844449</a></p></li><li><p>Zhi, J, et al., &amp; Sadowski, JA (1996). The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. <i>Journal of clinical pharmacology</i> 36(7) 659–666. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1996.tb04232.x\">10.1002/j.1552-4604.1996.tb04232.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8844450/\">https://pubmed.ncbi.nlm.nih.gov/8844450</a></p></li><li><p>Zhi, J, et al., &amp; Patel, IH (1995). The influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers. <i>Journal of clinical pharmacology</i> 35(5) 521–525. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1995.tb04098.x\">10.1002/j.1552-4604.1995.tb04098.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7657854/\">https://pubmed.ncbi.nlm.nih.gov/7657854</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A08AB01;
